Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fifth Third Bancorp Common Stock (FITB) vs Eli Lilly And Co (LLY) Price & Performance

Fifth Third Bancorp Common StockTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Fifth Third Bancorp Common Stock vs Eli Lilly And Co — how do they compare? Fifth Third Bancorp Common Stock trades at $51 (market cap $45.98B), while Eli Lilly And Co trades at $1,164.15 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 22.6× Fifth Third Bancorp Common Stock's market cap, and Fifth Third Bancorp Common Stock pays the higher dividend (3.31%). Which is the better fit depends on your goals — on Pluang, investors hold Fifth Third Bancorp Common Stock for 0 Days and Eli Lilly And Co for 93 Days on average.

FITBLLY
Market Cap
$45.98B$1.04T
Volume
10,522,3203,064,878
Sector
FinancialsHealth
52-Week High
$59.37$1.28K
52-Week Low
$40.36$799.57
Typical Hold Time
0 Days93 Days
Enterprise Value
$63.85B$1.09T
Dividend Yield
3.31%0.59%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fifth Third Bancorp Common Stock

No Aura AI signal available yet.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,188.72, up 2.7% on the day, with a bullish technical signal and strong fundamentals. Recent earnings beats, robust revenue growth to $65.18B in 2025, and a net income margin of 33.53% highlight operational strength. Positive news flow centers on next-generation weight-loss drugs, with analyst consensus bullish and a price target of $1,350.

Outlook remains positive given pipeline catalysts in obesity/diabetes markets, though high valuations (P/E 39.9) and rising debt levels pose risks. Competitive intensity and regulatory scrutiny are watchpoints, but institutional support and earnings momentum underpin further upside potential.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FITB
100% Buy0% Sell
Avg holding period · 0 Days
LLY
69% Buy31% Sell
Avg holding period · 93 Days

Top news

Latest headlines on both assets

About Fifth Third Bancorp Common Stock

Fifth Third Bancorp provides retail and commercial banking, lending, payments, and wealth management services in the United States.

Read more on FITB →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY →